NCT03152240

Brief Summary

TAPAC study is an an investigator-driven, observational, prospective,cohort aimed at evaluating differences between men and women in patients undergoing primary angioplasty : hospital medical care, successful markers myocardial reperfusion and the anatomical substrate by describing the underlying coronary anatomy will be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 12, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2019

Completed
Last Updated

February 27, 2019

Status Verified

February 1, 2019

Enrollment Period

1.3 years

First QC Date

May 4, 2017

Last Update Submit

February 26, 2019

Conditions

Keywords

Acute Coronary SyndromePrimary AngioplastyGender

Outcome Measures

Primary Outcomes (14)

  • Door-to-balloon time in patients

    Door-to-balloon time in patients

    90 minutes

  • Door-to-needle time in patients

    Door-to-balloon time in patients

    90 minutes

  • Time from onset of chest pain to first medical care

    Time from onset of chest pain to first medical care

    24 hours

  • Time from onset of chest pain to arrival Cath Lab

    Time from onset of chest pain to arrival Cath Lab

    24 hours

  • Time from onset of chest pain to artery opening

    Time from onset of chest pain to artery opening

    24 hours

  • Markers successful myocardial reperfusion by angiography

    ST segment resolution 90 minutes post-PCI (Percutaneous Coronary Intervention)

    First 90 min after reperfusion.

  • Markers successful myocardial reperfusion by angiography

    Final TIMI (Thrombolysis in Myocardial Infarction) flow grade

    First 90 min after reperfusion.

  • Markers successful myocardial reperfusion by angiography

    Final TIMI blush grade

    First 90 min after reperfusion.

  • Underlying coronary anatomy assessment

    Final TIMI Thrombus grade

    24 hours

  • Underlying coronary anatomy assessment

    Degree of difuse disease

    24 hours

  • Underlying coronary anatomy assessment

    Number of vessels involve

    24 hours

  • Underlying coronary anatomy assessment

    Percentage of Ventricular Ejection Fraction

    24 hours

  • Underlying coronary anatomy assessment

    Presence of significant Left Main disease

    24 hours

  • Underlying coronary anatomy assessment

    Degree of distal embolization

    24 hours

Secondary Outcomes (1)

  • Major adverse cardiac events (MACE)

    Hospital discharge and expected average of 1 week, one year follow-up

Study Arms (2)

Women patients

Women patients

Other: Non intervention

Men patients

Men patients

Other: Non intervention

Interventions

Non intervention

Men patientsWomen patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men and women undergoing coronary angioplasty.

You may qualify if:

  • Patients with:
  • Aged 18 years or over.
  • AMI (Acute Mycardial Infarction ) with ST segment elevation and indication of primary angioplasty in whom at least one diagnostic procedure with coronary angiography is performed.

You may not qualify if:

  • Patients with:
  • Life expectancy of less than one year.
  • Previous AMI.
  • Previous coronary revascularization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari Vall d'Hebron

Barcelona, 08035, Spain

Location

Related Publications (5)

  • Writing Group Members; Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26;133(4):447-54. doi: 10.1161/CIR.0000000000000366. No abstract available.

    PMID: 26811276BACKGROUND
  • 2. World Health Organization.The European Health Report2012: Chartingthe Wayto Well-being. Copenhagen, Denmark: World Health Organization Regional Office for Europe;2012

    BACKGROUND
  • Degano IR, Salomaa V, Veronesi G, Ferrieres J, Kirchberger I, Laks T, Havulinna AS, Ruidavets JB, Ferrario MM, Meisinger C, Elosua R, Marrugat J; Acute Myocardial Infarction Trends in Europe (AMITIE) Study Investigators. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 2015 Sep;101(17):1413-21. doi: 10.1136/heartjnl-2014-307310. Epub 2015 Apr 8.

    PMID: 25855798BACKGROUND
  • Garcia-Dorado D, Garcia del Blanco B. Door-to-balloon time and mortality. N Engl J Med. 2014 Jan 9;370(2):179. doi: 10.1056/NEJMc1313113. No abstract available.

    PMID: 24401062BACKGROUND
  • Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014 Nov;174(11):1822-30. doi: 10.1001/jamainternmed.2014.4762.

    PMID: 25265319BACKGROUND

MeSH Terms

Conditions

Myocardial InfarctionAcute Coronary SyndromeCoitus

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisSexual BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2017

First Posted

May 12, 2017

Study Start

November 1, 2017

Primary Completion

February 26, 2019

Study Completion

February 26, 2019

Last Updated

February 27, 2019

Record last verified: 2019-02

Locations